主体和额外终端域抑制剂对突肉瘤细胞的治疗潜力
Yuki Kotani1, Yoshinori Imura1, Sho Nakai1
1Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita 565-0871, Japan.
Cancers
|March 28, 2024
概括
基基因和额外终端域 (BET) 抑制剂对突肉瘤 (SS) 是一种罕见的癌症有前途. 这些药物向SS18-SSX融合基因,诱导细胞死亡并提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 突肉瘤 (SS) 是一种罕见的软组织恶性瘤,主要影响年轻人.
- 目前对SS的治疗有效性有限,这突显了对新型治疗策略的需求.
- SS18-SSX融合基因在SS病原和表观遗传调节中发挥着关键作用.
研究的目的:
- 为了研究原蛋白和额外终端域 (BET) 抑制剂在突肉瘤中的治疗潜力.
- 阐明SS中BET抑制剂抗瘤作用背后的分子机制.
- 探索SS18-SSX融合基因在SS对BET抑制的敏感性中的作用.
主要方法:
- 在体外研究中使用了四种SS细胞系.
- 用BET抑制剂ABBV-075来评估抗瘤作用.
- 进行细胞循环分析,细胞亡测定和RNA测序.
- 研究了SS18-SSX敲击对药物敏感性的影响.
主要成果:
- ABBV-075表现出显著的抗瘤活性,诱导SS细胞系的G1细胞周期停止和细胞亡.
- BET抑制剂调节了包括MYC,p21,CDK4和CDK6.6在内的关键细胞循环调节剂.
- RNA测序揭示了BCL2家族蛋白质表达的动态变化,特别是BCLxL/BIM比率,与亡相关.
- 增加BCL2表达的SS18-SSX敲击,降低了对ABBV-075.5的敏感性.
结论:
- BET抑制剂通过向SS18-SSX调节的内在亡途径,代表了对突肉瘤的一种有前途的治疗策略.
- BCLxL与BIM的表达比率可以预测患者对BET抑制剂治疗的反应.
- 针对SS18-SSX驱动的表观遗传失调,为SS治疗提供了一种新的方法.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


